Complete Genomics, Inc. (GNOM) Posts Narrower than Expected Q1 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St futures gain as oil slips; telecoms pressured by SpaceX spectrum deal
- Oil falls as Trump comments on Iran talks ease supply concerns
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- Telecom stocks tumble on SpaceX spectrum acquisition news
- Chipotle, Starbucks shares volatile after report of potential takeover
Tweet
Share
E-mailGet Alerts GNOM Hot Sheet
Join SI Premium – FREE
Complete Genomics, Inc. (NASDAQ: GNOM) reported Q1 EPS of ($0.48), $0.04 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $6.8 million versus the consensus estimate of $5.46 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Delta Air Lines (DAL) Misses Q3 EPS by 20c, Beats on Revenue; Cuts FY EPS Guidance
- Constellation Brands (STZ) Beats Q2 EPS by 13c, Revenue Beats, Offers Guidance
- Richardson Electronics (RELL) Tops Q1 EPS by 17c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
